Search results
4 results found Showing page 1 of 1
-
Valeant goes in search of a remedy with loans in danger of covenant breach
8 years ago
Painkillers won't do - large loan issuer Valeant Pharmaceuticals is going to need something stronger as it looks to stave off a possible default -
Valeant needs some painkillers after a Monday to forget
8 years ago
Beleaguered drugmaker Valeant Pharmaceuticals – one of the most widely-held names in the CLO market – was subject to yet more unwanted headlines yesterday -
Valeant's decision to drop Philidor is credit negative, says Moody's
8 years ago
Valeant Pharmaceuticals' decision to sever its relationship with Philidor is credit negative, according to Moody's -
CLOs may need treatment as Valeant's stock plummets
8 years ago
CLOs could be in for testing times after damaging allegations against widely-held leveraged loan issuer Valeant Pharmaceuticals were published yesterday
4 results found Showing page 1 of 1
Want all the latest news, comment, analysis and data?